Inhibition of mutagenic activation of orthoaminoazotoluene increases its carcinogenicity for mouse liver

Various mutationally impaired genes are often found in malignant tumors of animals and humans. At the same time, a large number of carcinogens demonstrate positive activity in different in vitro tests for mutagenicity. These findings are indicative of a geno- toxic mechanism of carcinogen action. It is considered that chemically active carcinogens induce mutations (and tumors) directly interacting with DNA, while inactive substances are mutagenically activated in the processes of cellular metabolism in target tissues. The aminoazo dyes was found to be activated by N-hydroxilation and subsequent conjugation with sulfuric acid catalyzed by the enzyme sulfotransferase. Previously we found that it is activated metabolites of ortho-aminoazotoluene that are responsible for its inhibitory effect on hormonal induction of tyrosinaminotransferase activity in the liver of sensitive mice. Inhibition of sulfoconjugation of 4-aminoazobenzene, another hepatocarcinogen for mice, by pentaclorophenol was reported to reduce its both mutagenic and carcinogenic activity. In this paper, we confirmed this observation. But we found that, when used ortho-aminoazotoluene, pentaclorophenol inhibited its mutagenic activity, but significantly stimulated the hepatocarcinogenic potency. It seems that carcinogenic action is provoked by unmetabolysed ortho-aminoazotoluene per se or some of its nonsulfated derivatives. The results of our comparative study with ortho-aminoazotoluene and 3.4-benzopyrene are in contradiction with the genotoxic theory of carcinogenesis: both are similarly activated by mouse liver enzymes, but induce tumors in different tissues: the former, hepatocellular carcinomas and the latter, splenic lymphoma. The conclusion was made that the accepted notion about the mechanism of carcinogenesis has to be revised.

1. Abilev S.K., Glazer V.M., Aslanyan M.M. Osnovy mutageneza i genotoksikologii [Fundamentals of Mutagenesis and Genotoxicology]. Moscow; Saint-Petersburg, 2012. (in Russian)

2. Ames D.N., Durston W.E., Yamasaki E., Lee F.D. Carcinogens are mutagens: a simple test system combining liver homogenates for activation and bacteria for detection. Proc. Natl Acad. Sci. USA.1973;70: 2281-2285.

3. Delclos K.B., Miller E.C., Miller J.A., Liem A. Sulfuric acid esters as major ultimate electrophilic metabolites of 4-aminoazobenzene and its N-methyl derivatives in infant male C57BL/6J × C3H/HeJ F1 (B6C3F1) mice. Carcinogenesis.1986;7:277-287.

4. Delclos K.B., Tarpley W.G., Miller E.C., Miller J.A. 4-aminoazobenzene and N,N-dimethyl-4- aminoazobenzene as equipotent hepatic carcinogens in mail C57BL/6 × C3H/He F1 mice and characterization of N-(deoxyguanosin-8-yl)-4-aminoazobenzene as the major persistent hepatic DNA-binding dye in these mice. Cancer Res. 1984;44:2540-2550.

5. De Vries A., Dolle M.E.T., Broekhof J.L.M., Muller J.J.A., Kroese E.D., van Kreijl C.F., Capel P.J.A., Vijg J., van Steeg H. Induction of DNA adducts and mutations in spleen, liver and lung of XPA-deficient/lacZ transgenic mice after oral treatment with benzo[α]pyrene: correlation with tumor development. Carcinogenesis. 1997;18:2327-2332.

6. Fennel T.R., Wiseman R.W., Miller J.A., Miller E.C. Major role of hepatic sulfotransferase activity in the metabolic activation, DNA adduct formation, and carcinogenicity of 1’- hydroxy-2’,3’-dehydroestragole in infant male C57BL/6J × C3H/HeJ F1 mice. Cancer Res. 1985;45:5310-5320.

7. Frolova T.S., Sinitsyna O.I., Kaledin V.I. The mutagenic activities of four aminoazo compounds with different carcinogenicities for rat liver in the Ames test. Biophysics. 2015;60:818-822.

8. Georgiev G.P. How a normal cell is transformed into a cancer one. Sorosovskiy obrazovatelnyy zhurnal = Soros Educational Journal. 1999;4:17-22. (in Russian)

9. Jones P.A., Baylin S.B. The epigenomics of cancer. Cell. 2007;128: 683-692.

10. Kaledin V.I., Galyamova M.R., Serova I.A., Ilnitskaya S.I., Nikitenko E.V., Schkurupii V.A. On sensitivity of adult males of C57BL/6 and C3H strains of mice to hepatic tumor induction by orthoaminoazotoluene. Byulleten SO RAMN = Bulletin of SB RAMS. 2002b;4(106):100-103. (in Russian)

11. Kaledin V.I., Gulyaeva L.F., Ilnitskaya S.I., Popova N.A., Bulycheva T.E. Glucocorticoid induction of tyrosine aminotransferase in the liver is impaired by activated metabolites of carcinogens. Doklady Akademii nauk SSSR = Reports of the Academy of Sciences of USSR. 1997;357:126-129. (in Russian)

12. Kaledin V.I., Ilnitskaya S.I. Metabolism inhibition enhances the carcinogenic action of o- aminoazotoluene in the mouse liver, whereas activation inhibits it. Voprosy onkologii = Problems in Oncology. 2011;57:216-220. (in Russian)

13. Kaledin V.I., Ilnitskaya S.I., Baginskaya N.V., Kholodar A.V., Obut T.A. Effect of phenobarbital and tyroxine on carcinogenesis induced in mice by nitrosoethylurea and diethylnitrosamine. Rossiyskiy fiziologicheskiy zhurnal im. I.M. Sechenova = I.M. Sechenov Physiological Journal. 2005;91:1481-1491. (in Russian)

14. Kaledin V.I., Ilnitskaya S.I., Ovchinnikova L.P., Popova N.A., Bogdanova L.A., Morozkova T.S. Mutagenic activation and carcinogenicity of aminoazo dyes ortho-aminoazotoluene and 3’- methyl- 4-dimethylaminoazobenzene in experiments on suckling mice. Biophysics. 2014a;59:431-435.

15. Kaledin V.I., Ilnitskaya S.I., Popova N.A., Baginskaya N.V., Bogdanova L.A., Perepechaeva M.L., Grishanova A.Yu. Inhibitory effect of ortho-aminoazotoluene on diethylnitrosamine- induced hepatocarcinogenesis in suckling mice. Phenomenon and possible mechanism. Biophysics. 2014b;59:635-641.

16. Kaledin V.I., Ilnitskaya S.I., Popova N.A., Koval O.A., Pyshnaya B.A., Gulyaeva L.F. Induction of tyrosine aminotransferase in mice is inhibited by the activated metabolites of ortho- aminoazotoluene. Vavilovskii Zhurnal Genetiki i Selektsii = Vavilov Journal of Genetics and Breeding. 2015;19(1):136-143. (in Russian)

17. Kaledin V.I., Ilnitskaya S.I., Vasyunina E.A., Popova N.A., Bogdanova L.A., Perepechaeva M.L., Grishanova A.Yu. The effect of changes in Cyp2e1 activity in the liver on toxicity and carcinogenicity of diethylnitrosamine in mice. Biophysics. 2015;60:970-976.

18. Kaledin V.I., Serova I.A., Semenova L.A. Different predisposition to development of spontaneous and induced tumors of the liver in mice of different strains and their hybrids. Eksperimentalnaya onkologiya = Experimental Oncology. 1990;12:28-30. (in Russian)

19. Kaledin V.I., Vasyunina E.A., Ovchinnikova L.P., Ronichevskaya G.M., Zvereva L.N., Ilnitskaya S.I. Search for correlation between the oncogenic and mutagenic effects of chemical carcinogens and gammairradiation in mice. Vestnik VOGiS = The Herald of Vavilov Society for Geneticists and Breeders. 2002a;21-22:11-19. (in Russian)

20. Kaledin V.I., Zakharova N.P. Vliyanie gepatokantserogennykh soedineniy na gormonalnuyu induktsiyu tirozinaminotransferazy v pecheni chuvstvitelnykh i rezistentnykh zhivotnykh [The influence of hepatocarcinogenic compounds on hormonal induction of tyrosine aminotransferase in the liver of sensitive and resistant animals]. Issledovaniya po induktsii i metastazirovaniyu zlokachestvennykh opukholey u eksperimentalnykh zhivotnykh [Studies on Tumor Induction and Metastasis in Experimental Animals]. Novosibirsk: ICG CO AN SSSR Publ., 1984;146-185. (in Russian)

21. Miller J.A. Carcinogenesis by chemicals: an overview. Cancer Res. 1970;30:658-664.

22. Miller J.A., Miller E.C. Kantserogennye aminoazosoedineniya [The carcinogenic aminoazodyes]. Uspekhi v izuchenii raka [Advances in Cancer Research]. Moscow, Inostrannaya literatura Publ., 1955;1: 7-71. (in Russian)

23. Miller E.C., Miller J.A. Searches for ultimate chemical carcinogens and their reactions with cellular macromolecules. Cancer. 1981;47:2327-2345.

24. Miller E.C., Swanson A.B., Phillips D.H., Fletcher T.L., Liem A., Miller J.A. Structure-activity studies of the carcinogenicities in the mouse and rat of some naturally occurring and synthetic alkenylbenzene derivatives related to safrole and estragole. Cancer Res. 1983;43:1124-1134.

25. Miller J.A., Miller E.C. The metabolic activation of carcinogenic aromatic amines and amides. Progr. Exptl. Tumor Res. 1969;11:273-301.

26. Nguen-Ba G., Vasseur P. Epigenetic events during the process of cell transformation induced by carcinogens (review). Oncol. Rep. 1999; 6(4):925-932.

27. Ovchinnikova L.P., Bogdanova L.A., Kaledin V.I. Mutagenic activation diminishes the carcinogenicity of ortho-aminoazotoluene in the mouse liver. Byulleten eksperimentalnoy biologii i meditsiny = Bulletin of Experimental Biology and Medicine. 2012;154:623-628. (in Russian)

28. Turusov V.C., Belitskii G.A., Pylev L.N., Koblyakov V.A. Mekhanizmy deystviya i klassifikatsiya khimicheskikh kantserogenov [The action pathways and classification of chemical carcinogens]. Kantserogenez. Red. D.G. Zaridze [Carcinogenesis. Ed. by D.G. Zaridze]. Moscow, Meditsina Publ., 2004;204-225. (in Russian)

29. Weisburger J.H., Yamamoto R.S., Williams G.M., Grantham P.H., Matsushima T, Weisburger E.K. On the sulfate ester of N-hydroxy- 2-fluorenylacetamide as a key ultimate hepatocarcinogen in the rat. Cancer Res. 1972;32:491-500.

30. Williams G.M., Klaiber M., Parker S.E., Farder E. Nature of early appearing, carcinogen- induced liver lesions resistant to iron fccumulation. J. Nat. Cancer Inst. 1976;57:157-165.

31. Zborovskaya I.B. Molekulyarno-biologicheskie issledovaniya onkogenov i genov-supressorov opukholevogo rosta v klinicheskoy praktike [Molecular study of oncogenes and genes suppressing tumor growth in clinical practice]. Kantserogenez. Red. D.G. Zaridze [Carcinogenesis. Ed. by D.G. Zaridze]. Moscow, Meditsina Publ., 2004. (in Russian)

32. Zeiger E. Mutagens that are not carcinogens: faulty theory or faulty tests? Mutat. Res. 2001;492:29-38.